ArticleOncotarget2015

Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.

Guo-Qing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.